溶栓疗法合用抗凝剂治疗恶性肿瘤患者静脉血栓16例临床分析  

Treatment of Thrombolysis and Anticoagulant for Malignant Veinous Embolus:16 Cases Reports

作　　者：吕宗渤[1] 王健[1] 

机构地区：[1]天津医科大学附属肿瘤医院急诊科,天津300060

出　　处：《肿瘤防治杂志》2003年第5期528-529,共2页China Journal of Cancer Prevention and Treatment

摘　　要：目的 :观察溶栓疗法合用小剂量抗凝剂治疗恶性肿瘤患者静脉血栓形成的临床疗效。方法 :尿激酶合用小剂量肝素治疗恶性肿瘤患者静脉血栓形成 ,并观察其有无出血、复发及过敏反应。结果 :16例中 13例 (81 3% )患者肢体肿胀均完全消退 ,消肿时间 5～ 11d ,另 3例 (18 8% )患者肢体肿胀均有不同程度减轻。治疗期间未发现出血倾向及过敏反应。治疗后随访 4周 ,无 1例复发。结论 :溶栓疗法合用小剂量抗凝剂治疗恶性肿瘤患者静脉血栓形成疗效较好 ,且不易复发、安全、经济 。Objective To investigate the clinical efficacy of thrombolysis combined with low dose of anticoagulant to treat the malignant veinous embolus.Methods Sixteen cases of malignant veinous embolus were treated with urokinase and low dose of heparin,and the hematorrhea,recurrence and allergy were observed strictly.Results Thirteen cases of legs edema were cured during the period of 5-11 days.Another 3 cases were reductive.There was no hematorrhea and allergy during the treatment.The following time was 4 weeks and there was no recurrent case.Conclusion The treatment efficacy of thrombolysis and low dose of anticoagulant for the malignant veinous embolus is good,hardly recurrent,safe,cheap and easily received by patients. China J Cancer Prev Treat,2003,10(5):528-529

关 键 词：肿瘤 并发症 静脉血栓 溶栓疗法 抗凝剂 联合治疗 血栓性静脉炎 药物疗法 

分 类 号：R730.5[医药卫生—肿瘤]